Microvascular prothrombogenicity and transplant coronary artery disease

By Labarrere C.A.   Deng M.C.  

Transplant Immunology, Vol. 9, Iss. 2, 2002-05 ,pp. : 243-249

Elsevier

Access to resources Recommend Favorite

Inducible nitric oxide synthase is upregulated in human transplant coronary artery disease

By Ravalli S.   Szabolcs M.   Barbone A.   Albala A.   Michler R.E.   Cannon P.J.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2579-2580

Elsevier

Access to resources Recommend Favorite

Influence of Donor/Recipient Phenotype and Degree of HLA Mismatch on the Development of Transplant-Associated Coronary Artery Disease in Heart Transplant Patients

By Hornick P.   Smith J.   Pomerance A.   Banner N.   Mitchell A.   Rose M.   Yacoub M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1420-1421

Elsevier

Access to resources Recommend Favorite

Midterm results of percutaneous transluminal coronary angioplasty in graft coronary artery disease in cardiac transplant patients

By Marelli M.   Rabago G.   Calabuig J.   Martnez Caro D.   Coma-Canella I.   Martn Trenor A.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2539-2541

Elsevier

Access to resources Recommend Favorite

Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease

By Kato T.   Tokoro T.   Namii Y.   Kobayashi T.   Hayashi S.   Yokoyama I.   Morimoto S.   Chan M.   Giannetti N.   Hunt S.A.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 331-333

Elsevier

Access to resources Recommend Favorite